FTC clears way for Linde acquisition of Lincare

CLEARWATER, Fla., July 23, 2012—The Linde Group and Lincare Holdings Inc. announced that the Federal Trade Commission has granted early termination of a waiting period under antitrust laws. This step is necessary for the acquisition of Lincare by Linde for $4.6 billion.

Under the terms of an agreement, Linde will make a tender offer for all outstanding shares of common stock of Lincare at $41.50 per share in cash. Linde is a German company specializing in industrial gases, and Lincare is a leading U.S. provider of respiratory therapy, oxygen and other home medical services.

For more information, go to the Linde website and Lincare website.